Sheel Bio. Stock Price Today (NSE: SHEEL)

Sheel Bio.

72.00+0.00 (+0.00%)
Market Closed

Fundamental Score

...

Sheel Bio. Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Sheel Bio. share price today is 72.00, up +0.00% on NSE/BSE as of 1 August 2026. Sheel Bio. (SHEEL) is a Small-cap company in the Diversified Commercial Services sector with a market capitalisation of 146.53 (Cr). The 52-week high for SHEEL share price is N/A and the 52-week low is N/A. At a P/E ratio of 12.46x, SHEEL is currently trading below its industry average P/E of 19.79x. The company has a Return on Equity (ROE) of 14.03% and a debt-to-equity ratio of 0.32.

Sheel Bio. Share Price Chart — NSE/BSE Historical Performance

No data
High
72.00
Low
72.00
Volume
0
Change
+0.00%

Sheel Bio. share price chart: 0.00% return over the past month. 52-week high ₹N/A, 52-week low ₹N/A.

AI Research Briefing

Powered by Gemini · 2026-08-01

Surging Q4 profits and promoter creeping acquisition mask toxic 5-year FCF of ₹-7.99 Cr, making this SME play strictly a tactical momentum trade.

Research Confidence
4.5/10Low
MICRO-CAP DARK HORSEBreakout — 3M performance up 48.3% and 1M performance up 14.29%.Cheap — P/E of 12.46x vs Industry P/E of 19.79x.

WHAT'S HAPPENING NOW (last 2-4 weeks)

No major catalysts found after live search. The latest regulatory event was an exchange clarification sought regarding Regulation 33 on June 24, 2026. Prior market activity saw a bulk deal on June 18, 2026, where Bakul Chaturbhai Limbasiya purchased 150,000 shares. Standalone FY26 financials recorded operational revenue growth of 8.1% YoY to ₹110.02 Cr and net profit expansion of 9.3% YoY to ₹11.76 Cr.

CORE STORY (THE REAL GAME)

This is an SME micro-cap tissue culture and agri-biotech operator play riding government policy thrust toward bio-fertilizers and commercial seedling propagation. It is not a proprietary genomics platform; it is a volume-dependent plant tissue culture supplier where reported accounting profits frequently fail to manifest as free cash flow.

Why Now
  • No major catalysts found after live search in the last 4 weeks.
  • Promoter holding increased by 1.04% to 72.30% in recent reporting.
  • Q4 YoY net profit jump of 105.03% provides residual momentum.
Potential Catalysts
  • Q1 FY27 earnings report proving Q4 revenue surge was not a one-off.
  • Fresh institutional inflows or DII position scaling beyond 9.49%.
  • Sustained execution on government bio-fertilizer contracts.
Key Risks
  • Micro/SME cap status creating severe liquidity and execution risk.
  • Negative 5-year cumulative Free Cash Flow of ₹-7.99 Cr.
  • Foreign Institutional Investors (FIIs) completely exited to 0.00%.
Institutional Activity

Promoters raised stake by +1.04% to 72.30%, DIIs hold 9.49%, while FIIs completely dumped holding to 0.00%.

Macro Context

Government push for green agriculture and organic inputs provides macro tailwinds for SME biotech suppliers.

Order Book / Expansion

No major news found after live search.

Cash Flow Quality

No — 5-year Free Cash Flow remains negative at ₹-7.99 Cr.

3–6 Month Outlook

Short-term momentum intact post Q4 numbers, but poor long-term cash generation limits 3-6 month holding conviction.

Primary Thesis Risk

Illiquid SME structure combined with negative long-term cash conversion.

For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.

Returns & Performance

Poor

Return on Equity (ROE)

14.03%

Profit generated per ₹1 of shareholder equity

Average

Return on Capital (ROCE)

15.73%

Returns generated on total capital deployed

Good

Oper. Profit Margin (5Y Avg)

12.26%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Sheel Bio. Valuation Check

Excellent

Price to Earnings (P/E)

12.46x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

19.79x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

72.30%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Average

DII Holding

9.49%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Excellent

Profit Growth (Quarterly YoY)

105.03%

Net profit growth vs same quarter last year

Excellent

Revenue Growth (Quarterly YoY)

93.71%

Revenue growth vs same quarter last year

Good

Revenue Growth (5-Year CAGR)

11.80%

Compounded annual revenue growth over 5 years

Poor

EPS Growth (5-Year CAGR)

-12.62%

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

20.13%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.32x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

8.34x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-7.99 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Sheel Bio. Fundamental Analysis & Valuation Benchmarking

Educational evaluation of SHEEL across key market metrics for learning purposes.

Positive Indicators

8 factors identified

Excellent ROCE Performance (15.73%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.

Attractive Valuation (P/E: 12.46 vs Industry: 19.79)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity.

Robust Profit Growth (105.03%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Strong Revenue Growth (93.71%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Strong Profit Growth Track Record (20.13% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Strong Interest Coverage (8.34x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Balanced Promoter Holding (72.30%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

4 factors identified

Weak Earnings Growth (-12.62% CAGR)

Observation: Below-average 5-year EPS growth performance.

Analysis: Low EPS growth may not keep pace with inflation.

Negative Free Cash Flow (₹-7.99 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

Limited Institutional Interest (FII+DII: 9.49%)

Observation: Low institutional participation may affect liquidity.

Analysis: Limited institutional interest may indicate size constraints or visibility issues.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Sheel Bio. vs Diversified Commercial Services Peers

Peer Comparison -

Compare Sheel Bio. with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
60.5/100
72
₹146.53
12.5
Average
14.03%
Average
15.73%
Good
0.3
Excellent
20.13%
Excellent
11.80%
Good
0.00%
72.2/100
353
₹15268.32
26.2
Average
23.22%
Excellent
30.72%
Excellent
0.0
Excellent
67.78%
Excellent
48.99%
Excellent
0.71%
44/100
547
₹9993.10
130.6
Average
29.74%
Excellent
20.57%
Excellent
18.2
Poor
16.26%
Excellent
30.59%
Excellent
0.00%
Nesco Ltd...
NESCO505355
68.3/100
1065
₹7688.93
18.4
Average
14.84%
Average
18.54%
Good
0.1
Excellent
19.33%
Excellent
26.21%
Excellent
0.64%
50.4/100
170
₹7685.07
74.4
Average
5.62%
Poor
8.42%
Poor
0.1
Excellent
21.46%
Excellent
10.28%
Good
0.00%
61/100
16
₹7318.76
22.6
Average
23.06%
Excellent
16.17%
Good
0.1
Excellent
36.58%
Excellent
37.68%
Excellent
0.00%
10.1/100
135
₹6185.81
65.4
Average
2.47%
Poor
5.08%
Poor
0.6
Good
5.66%
Nirlon Ltd...
NIRLON500307
63.3/100
619
₹5787.56
16.7
Average
83.82%
Excellent
30.77%
Excellent
2.5
Poor
22.12%
Excellent
16.12%
Excellent
4.04%
55.7/100
471
₹5287.73
502.2
Average
3.30%
Poor
8.30%
Poor
9.0
Poor
17.02%
Excellent
45.06%
Excellent
0.00%
39.7/100
264
₹4465.92
14.4
Average
13.20%
Average
17.65%
Good
0.1
Excellent
13.06%
Good
13.75%
Good
2.41%
53.2/100
333
₹4382.22
19.1
Average
20.38%
Excellent
23.04%
Excellent
0.1
Excellent
37.55%
Excellent
7.15%
Good
3.41%

Sheel Bio. Quarterly Performance

Latest quarterly metrics for SHEEL — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

93.71%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

105.03%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

11.80%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

20.13%

Compounded annual net profit growth over 5 years

Sheel Bio. Financial Statements

Annual income statement, balance sheet and cash flow for Sheel Bio. (SHEEL) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Sheel Bio.

About SHEEL (Sheel Bio.)

Sheel Bio. (SHEEL) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Diversified Commercial Services sector with ...a current market capitalisation of ₹146.53 (Cr). Sheel Bio. has delivered a Return on Equity (ROE) of 14.03% and a ROCE of 15.73%. The debt-to-equity ratio stands at 0.32, reflecting the company's capital structure. Investors tracking SHEEL share price can monitor key metrics including P/E ratio, promoter holding of 72.30%, and quarterly earnings growth.

Company Details

Symbol:SHEEL
Industry:Diversified Commercial Services
Sector:N/A
Website:N/A

SHEEL Share Price: Frequently Asked Questions

What is the current share price of Sheel Bio.?

Sheel Bio. (SHEEL) trades at ₹72.00 on NSE. Market cap ₹146.53 (Cr). Educational data only.

What is the P/E ratio of Sheel Bio.?

Sheel Bio. has a P/E of 12.46x vs industry average 19.79x.

What is the Bull Run score for Sheel Bio.?

Sheel Bio. has a Bull Run score of 60.5/100 based on 25+ financial parameters.

Does Sheel Bio. pay dividends?

Sheel Bio. has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Sheel Bio.?

Sheel Bio. has ROE of 14.03%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Sheel Bio.?

Sheel Bio. has debt-to-equity of 0.32.

Is Sheel Bio. a good investment?

Bull Run gives Sheel Bio. a score of 60.5/100. This is not investment advice — consult a SEBI-registered advisor.